Roche has received the US Food and Drug Administration (FDA) approval for its Accu-Chek Aviva Plus test strip.
The test strip is designed to prevent the interference of maltose on blood sugar readings.
The Accu-Chek Aviva Plus test strip aids patient to self-monitor the blood glucose and can also be used with the Accu-Chek Aviva system.
Roche Diagnostics COO Daniel Day said they are pleased to announce that their new product for self-monitoring of blood glucose will also be available for people with diabetes in the US.
"With its advanced technology and chemistry it is designed to support patients to manage their condition more effectively," Day said.